Kundenportale
Get the updates in your inbox
Subscribe to get the latest news and updates.
No spam. We promise.
Second medical use patents in Brazil
Swiss-type patent claims are vital for incentivizing the development of inventions directed to second medical uses and require special consideration in Brazil.
The thin line between fake and fine
AI-generated designs, lookalike products and social media counterfeits are reshaping the luxury landscape. Explore how high-end brands can defend their identity in a world of fast fakes.
Structure and change: the UPC stretches forth as patent filings remain steady
Some top IP news stories from the last weeks: the European Patent Office (EPO) releases its annual coverage of filing demand as the Unified Patent Court (UPC) reaches across borders.
Everyday IP: Breaking the law without knowing it
Sometimes, Intellectual Property (IP) rights can be infringed by ordinary actions, leading to extraordinary consequences for both the owners and the unintentional violators.
World IP Day: Feel the beat of rights, royalties and innovation
We celebrate World IP Day 2025 with a look at the influence of personal brands, streaming, digital collaboration and AI on the music scene.
From certificates to courts: litigating second medical use patents
Can further medical uses be eligible for extended protection, and how have Brexit and the UPC affected the situation?
The continuing debate over second medical use patents
Pursuing exclusive rights in Europe for new medical applications of known therapeutics requires close consideration of legal precedent.
Editor's pick
How are damages calculated in patent infringement cases?
If the worst should happen, an inventor must understand how patent infringement damages are calculated in major legal jurisdictions.
Everyday IP: Brewing the finest booze – beer through the ages
As one of the world's oldest beverages, it is no surprise that beer and its history offer intriguing lessons about innovation and Intellectual Property.
Everyday IP: When were computers invented?
Answering the question: 'When were computers invented?' involves far more than just citing a date — it is bound up in the past, present and future of IP.
What it means to be in Intellectual Property
Working in the Intellectual Property industry takes many forms, requiring professionals with diverse backgrounds and skillsets.
Discover in...
Patents
Second medical use patents in Brazil
Swiss-type patent claims are vital for incentivizing the development of inventions directed to second medical uses and require special consideration in Brazil.
From certificates to courts: litigating second medical use patents
Can further medical uses be eligible for extended protection, and how have Brexit and the UPC affected the situation?
The continuing debate over second medical use patents
Pursuing exclusive rights in Europe for new medical applications of known therapeutics requires close consideration of legal precedent.
Trademarks
The thin line between fake and fine
AI-generated designs, lookalike products and social media counterfeits are reshaping the luxury landscape. Explore how high-end brands can defend their identity in a world of fast fakes.
Trademarks and global rebranding
Refreshing a corporate image is a high-stakes game; playing it right requires careful consideration of trademarks and other IP rights.
Trademark exhaustion and resale markets
Are there circumstances where trademark owners can object to how their goods are resold? Find out more.
Industry News
Structure and change: the UPC stretches forth as patent filings remain steady
Some top IP news stories from the last weeks: the European Patent Office (EPO) releases its annual coverage of filing demand as the Unified Patent Court (UPC) reaches across borders.
Altering IP: regulations, resolutions and revisions
Catch up with current developments in IP, including the EU Commission's move to shelve draft legislation on SEPs.
Legal fiction: the rise of fake representatives and other IP news
Examining Intellectual Property (IP) stories from recent months allows us to gauge what 2025 might have in store.
